TOX as a potential target for immunotherapy in lymphocytic malignancies
Sign Up to like & getrecommendations! Published in 2021 at "Biomarker Research"
DOI: 10.1186/s40364-021-00275-y
Abstract: TOX (thymocyte selection-associated HMG BOX) is a member of a family of transcriptional factors that contain the highly conserved high mobility group box (HMG-box) region. Increasing studies have shown that TOX is involved in maintaining… read more here.
Keywords: lymphocytic malignancies; potential target; tox potential; target immunotherapy ... See more keywords